Targeted hepatic delivery of ezetimibe via red blood cell-coated nanoparticles for the treatment of non-alcoholic fatty liver disease through inflammation modulation

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 99224fafacd135d6-IAD IP: 47.97.18.252 UTC time: 2025-10-21T17:00:27+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4